Variant report
Variant | nsv966965 |
---|---|
Chromosome Location | chr3:158947307-158950936 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:158949275..158950779-chr3:158953655..158955845,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs76465824 | chr3:158947325-158947326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs544935617 | chr3:158947342-158947343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs75477505 | chr3:158947344-158947345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs376624502 | chr3:158947364-158947365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs578090939 | chr3:158947411-158947412 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs545509351 | chr3:158947412-158947413 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs144049999 | chr3:158947416-158947417 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs182279697 | chr3:158947440-158947441 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs575141157 | chr3:158947465-158947466 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs542419171 | chr3:158947471-158947472 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs112124817 | chr3:158947504-158947505 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs112359138 | chr3:158947508-158947509 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs112775374 | chr3:158947522-158947523 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs561154121 | chr3:158947524-158947525 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs531480827 | chr3:158947527-158947528 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs188041550 | chr3:158947528-158947529 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs536660752 | chr3:158947535-158947536 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs201040591 | chr3:158947542-158947543 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs190957473 | chr3:158947543-158947544 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs183131496 | chr3:158947550-158947551 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs111952574 | chr3:158947564-158947565 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs113185904 | chr3:158947573-158947574 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs529266055 | chr3:158947605-158947606 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs549695753 | chr3:158947629-158947630 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs371790090 | chr3:158947659-158947660 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs188745985 | chr3:158947660-158947661 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs192832303 | chr3:158947687-158947688 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs370712270 | chr3:158947696-158947697 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs184918675 | chr3:158947701-158947702 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs187800337 | chr3:158947739-158947740 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs372547780 | chr3:158947764-158947765 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs13314849 | chr3:158947792-158947793 | Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs9823142 | chr3:158948866-158948867 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs534728585 | chr3:158948867-158948868 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs35967275 | chr3:158948871-158948872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs189461378 | chr3:158948888-158948889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs575831640 | chr3:158948917-158948918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs143386287 | chr3:158948940-158948941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs9823574 | chr3:158948959-158948960 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs2244434 | chr3:158948969-158948970 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs148387525 | chr3:158948977-158948978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs559064761 | chr3:158949003-158949004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs529727825 | chr3:158949016-158949017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs140549825 | chr3:158949052-158949053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs147076576 | chr3:158949106-158949107 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs530631103 | chr3:158949113-158949114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs550362691 | chr3:158949115-158949116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs577219468 | chr3:158949141-158949142 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs571889692 | chr3:158949146-158949147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs138485147 | chr3:158949183-158949184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16608533 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Breast cancer | 21509527 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:158946800-158947400 | Enhancers | Dnd41 | blood |
2 | chr3:158947000-158947400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
3 | chr3:158947000-158947400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
4 | chr3:158947000-158947400 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
5 | chr3:158947400-158947600 | Active TSS | HSMM | muscle |
6 | chr3:158947600-158947800 | Flanking Active TSS | HSMM | muscle |
7 | chr3:158948800-158949200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
8 | chr3:158949200-158952000 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |